β³ Fetching live dividend data...
Home βΊ Calculator βΊ QTTB Dividend Calculator 2026
Q32 Bio Inc. Β· NASDAQ
Price: $13.81 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in QTTB β $11.79M in 10 years Β· $138.98/month
Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States. Its lead product candidate is ADX-097, a humanized anti-C3d monoclonal antibody fusion protein to restore complement regulation, which has completed Phase I clinical trial for the treatment of renal and other complement-mediated diseases of high unmet need, including lupus nephritis, immunoglobulin A nephropathy, complement component 3 glomerulopathy, and anti-neutrophil cytoplasmic antibody-associated vasculitis. The company is also developing Bempikibart (ADX-914), a fully human antiΒinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin that is Phase II clinical trial for the treatment of atopic dermatitis and alopecia areata. Q32 Bio Inc. was formerly known as AdMIRx Inc. and changed its name to Q32 Bio Inc. in April 2020. The company was founded in 2017 and is based in Waltham, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open QTTB position with:
Real after-tax yield depends on where you live and how you hold QTTB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 14.48% | 11.68% | $1,448 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 12.31% | 9.51% | $1,231 / yr |
| πΊπΈ US Taxable (20%) | 20% | 11.58% | 8.78% | $1,158 / yr |
| π¬π§ UK ISA | 0% | 14.48% | 11.68% | $1,448 / yr |
| π¬π§ UK Taxable | 8.75% | 13.21% | 10.41% | $1,321 / yr |
| π¨π¦ TFSA | 0% | 14.48% | 11.68% | $1,448 / yr |
| π¨π¦ CA Taxable | 25% | 10.86% | 8.06% | $1,086 / yr |
| π¦πΊ Super (pension) | 15% | 12.31% | 9.51% | $1,231 / yr |
| π¦πΊ AU Taxable | 30% | 10.14% | 7.34% | $1,014 / yr |
| π©πͺ DE Taxable | 26.375% | 10.66% | 7.86% | $1,066 / yr |
| π«π· FR Taxable | 30% | 10.14% | 7.34% | $1,014 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
QTTB pays quarterly β 4 times per year. Next ex-div: TBD.
How QTTB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for QTTB sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-05-28 | 1,250,000 | $8.00 | $10.00M | ||
| Buy | 2026-05-28 | 625,000 | $8.00 | $5.00M | ||
| Buy | 2026-05-28 | 1,250,000 | $8.00 | $10.00M | ||
| Buy | 2026-05-28 | 625,000 | $8.00 | $5.00M | ||
| A-Award | 2026-02-24 | 37,500 | β | β | ||
| A-Award | 2026-02-24 | 132,000 | β | β | ||
| A-Award | 2026-02-24 | 53,250 | β | β | ||
| Sale | 2026-02-25 | 3,995 | $4.51 | $18.0K | ||
| Sale | 2026-02-25 | 9,896 | $4.51 | $44.7K | ||
| Sale | 2026-02-25 | 2,815 | $4.51 | $12.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Insiders are net buyers β historically a positive signal for dividend sustainability. Last purchase: 2026-05-28
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the QTTB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β